- Acquired by Nextage Therapeutics for $21M, Sep 2023
- Raised $370k grant, Jun 2022
About
Nextar Chempharma Solutions Ltd. is an Israeli biotechnology company that develops and manufactures innovative pharmaceuticals and medical devices. The company offers a suite of integrated contract drug development and manufacturing services for small molecules, including formulation development, analytical development, and manufacturing for various dosage forms. Nextar has helped bring over 180 products to market as a contract development and manufacturing organization (CDMO) and for its own portfolio. The company is also developing a proprietary Brain-Transported Liposomes (BTLs) platform, which can deliver generic and innovative drugs across the blood-brain barrier (BBB) into the brain, with its first product based on this platform currently in development for the treatment of glioblastoma. Nextar is certified to OECD-GLP, EU-cGMP, ISO 13485, and ISO 9001.
Funding history · 1 round · $370K total
Headcount over time
Q&A
- What is Nextar Chempharma Solutions' primary business?
- Nextar Chempharma Solutions specializes in contract drug development and manufacturing, focusing on drugs and medical devices.
- When was Nextar Chempharma Solutions founded?
- Nextar Chempharma Solutions was founded in July 2007.
- What is Nextar Chempharma Solutions' proprietary technology?
- Nextar Chempharma Solutions has a proprietary Brain Targeted Liposomes platform designed to facilitate targeted delivery of drugs across the blood-brain barrier and into the brain.
- How many employees does Nextar Chempharma Solutions have?
- Nextar Chempharma Solutions has 11-50 employees.
- What was Nextar Chempharma Solutions' most recent funding round?
- In July 2022, Nextar Chempharma Solutions received a Grant round totaling $370,000.
- Who is the Founder and CEO of Nextar Chempharma Solutions?
- Orna Dreazen is the Founder and CEO of Nextar Chempharma Solutions.
- What is the current stage of Nextar Chempharma Solutions?
- Nextar Chempharma Solutions is currently in the 'Acquired' stage.
- In which country is Nextar Chempharma Solutions headquartered?
- Nextar Chempharma Solutions is headquartered in Ness Ziona, Israel.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | nextar.co.il |
|---|---|
| linkedin.com/company/526053 | |
| facebook.com/Nextar-Chempharma-Solutions-176188249232201 | |
| YouTube | youtube.com/channel/UCQ-QZUq5AYfeaGmUz0E2MtQ |
Identifiers & details
| Legal name | Nextar Chempharma Solutions Ltd. |
|---|---|
| Founded | 2007-7 |
| Employees (exact) | 31 |
Acquisitions & public offerings
Acquired by Nextage Therapeutics 2023-09 $21.0M
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | nextar.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514011113 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2007-07-31 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2021 |
| Active charges / liens | 0 |
| Registry events | 2 — people (1), other (1) |
| Registered address | אינשטיין 13 נס ציונה |
Recent registry events
| Date | Event |
|---|---|
| 2025-07-16 | עדכון בעלי תפקידים |
| 2025-12-15 | עדכון חיובים במג~ק |